Eugene Helsel
General Counsel bei Artiva Biotherapeutics, Inc.
Profil
Eugene Helsel is currently the Vice President of Regulatory Affairs & Quality at Artiva Biotherapeutics, Inc. Prior to this, he worked as the Senior Director of Regulatory Affairs at Capricor, Inc. and as the Executive Director of Regulatory Affairs & Quality at Fate Therapeutics, Inc. He received his undergraduate degree from National University and the University of California San Diego.
Aktive Positionen von Eugene Helsel
| Unternehmen | Position | Beginn |
|---|---|---|
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | General Counsel | - |
Ehemalige bekannte Positionen von Eugene Helsel
| Unternehmen | Position | Ende |
|---|---|---|
| FATE THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Capricor, Inc.
 Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | Corporate Officer/Principal | - |
Ausbildung von Eugene Helsel
| University of California San Diego | Undergraduate Degree |
| National University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| FATE THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Health Technology |
Capricor, Inc.
Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | Health Technology |
